Health Care & Life Sciences » Pharmaceuticals | Sinclair Pharma PLC

Sinclair Pharma PLC | Income Statement

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
55,378.00
63,559.00
75,887.00
30,326.20
45,300.00
Cost of Goods Sold (COGS) incl. D&A
26,529.00
34,117.00
37,139.00
13,463.40
17,415.00
Gross Income
28,849.00
29,442.00
38,748.00
16,862.80
27,885.00
SG&A Expense
27,427.00
27,860.00
32,761.00
33,711.50
33,990.00
EBIT
1,422.00
1,582.00
5,987.00
18,048.80
6,105.00
Unusual Expense
17,995.00
4,571.00
1,457.00
2,513.00
2,099.00
Non Operating Income/Expense
390.00
668.00
6,813.00
342.40
70.00
Interest Expense
796.00
2,120.00
5,869.00
1,812.70
283.00
Pretax Income
16,977.00
4,441.00
8,152.00
22,686.80
4,343.00
Income Tax
1,128.00
348.00
944.00
422.70
3,669.00
Consolidated Net Income
15,849.00
4,093.00
7,208.00
22,264.10
674.00
Net Income
15,849.00
4,093.00
7,208.00
22,264.10
674.00
Net Income After Extraordinaries
14,334.00
2,885.00
7,208.00
25,659.80
1,309.00
Net Income Available to Common
17,364.00
5,301.00
7,208.00
21,413.40
39.00
EPS (Basic)
0.04
0.01
0.01
0.04
0.00
Basic Shares Outstanding
426,575.80
444,757.70
496,983.70
497,791.40
503,360.20
EPS (Diluted)
0.04
0.01
0.01
0.04
0.00
Diluted Shares Outstanding
426,575.80
444,757.70
496,983.70
497,791.40
503,360.20
EBITDA
6,604.00
8,067.00
15,001.00
13,230.10
681.00
Other Operating Expense
-
-
-
1,200.00
-
Non-Operating Interest Income
2.00
-
-
30.00
16.00

About Sinclair Pharma

View Profile
Address
Whitfield Court
London Greater London W1T 2RQ
United Kingdom
Employees -
Website http://sinclairispharma.com
Updated 09/14/2018
Sinclair Pharma Plc is an aesthetic dermatology company, which provides aesthetic dermatology solutions through collagen stimulation for facial volume loss, thread lifting for facial contouring, and dermal fillers for wrinkles and lines. It operates through the following business segments: Country Operations, and International Operations. The Country Operations segment comprises the proprietary sales infrastructure from the operations in France, the United Kingdom, Italy, Germany, and Spain.